This dataset contains forecasted weekly numbers of reported COVID-19 incident cases, incident deaths, and cumulative deaths in the United States, previously reported on COVID Data Tracker (https://covid.cdc.gov/covid-data-tracker/#datatracker-home). These forecasts were generated using mathematical models by CDC partners in the COVID-19 Forecast Hub (https://covid19forecasthub.org/doc/ensemble/). A CDC ensemble model was produced every week using the submitted models from that week at the national, and state/territory level.

This dataset is intended to mirror the observed and forecasted data, previously available for download on the CDC’s COVID Data Tracker. Mortality forecasts for both new and cumulative reported COVID-19 deaths were produced at the state and territory level and national level. Forecasts of new reported COVID-19 cases were produced at the county, state/territory, and national level. Please note that this dataset is not complete for every model, date, location or combination thereof. Specifically, county level submissions for COVID-19 incident cases were accepted, but not required, and are missing or incomplete for many models and dates. State and territory-level forecasts are more complete, but not all models submitted forecasts for all locations, dates, and targets (new reported deaths, new reported cases, and cumulative reported deaths). Forecasts for COVID-19 incident cases were discontinued in February 2022. Forecasts for COVID-19 cumulative and incident deaths were discontinued in March 2023.

View daily updates and historical trends for Arkansas Coronavirus Cases Currently Hospitalized. Source: US Department of Health & Human Services. Track ec…

The counties of Trousdale and Lake – both in Tennessee – had the highest COVID-19 infection rates in the United States as of June 9, 2020. Dakota, Nobles, and Lincoln also ranked among the U.S. counties with the highest number of coronavirus cases per 100,000 people.

Coronavirus hits the East Coast In the United States, the novel coronavirus had infected around 5.4 million people and had caused nearly 170,000 deaths by mid-August 2020. The densely populated states of New York and New Jersey were at the epicenter of the outbreak in the country. New York City, which is composed of five counties, was one of the most severely impacted regions. However, the true level of transmission is likely to be much higher because many people will be asymptomatic or suffer only mild symptoms that are not diagnosed.

All states are in crisis The first coronavirus case in the U.S. was confirmed in the state of Washington in mid-January 2020. At the time, it was unclear how the virus was spreading; we now know that close contact with an infected person and breathing in their respiratory droplets is the primary mode of transmission. It is no surprise that the four states with the most coronavirus cases are those with the highest populations: New York, Texas, Florida, and California. However, Louisiana was the state with the highest COVID-19 infection rate per 100,000 people as of August 24, 2020.

This Project Tycho dataset includes a CSV file with COVID-19 data reported in UNITED STATES OF AMERICA: 2019-12-30 - 2021-07-31. It contains counts of cases, deaths, hospitalizations, and demographics. Data for this Project Tycho dataset comes from: "Alabama Department of Public Health Website Dashboard", "Arkansas Department of Health COVID-19 Website Dashboard", "California Health and Human Services Open Data Portal, California Department of Public Health COVID-19 Data", "Colorado Department of Public Health and Environment Open Data Website", "Connecticut Open Data Website, Department of Public Health COVID-19 Data", "Delaware Environmental Public Health Tracking Network, Delaware Health and Social Services Website", "Georgia Department of Public Health Website", "Illinois Department of Public Health Website", "Indiana Data Hub Website, Indiana State Department of Health COVID-19 Data", "COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University", "Kentucky Department of Public Health COVID-19 Website Dashboard", "Maine Center for Disease Control & Prevention; Division of the Maine Department of Health and Human Services Website", "Maryland Department of Health COVID-19 Website Dashboard", "Minnesota Department of Health COVID-19 Website Dashboard", "Montana Department of Health & Human Services COVID-19 Website Dashboard", "New York State Department of Health Data Website", "COVID-19 Data Repository by The New York Times", "Ohio Department of Health COVID-19 website", "Pennsylvania Department of Health Data Website", "Tennessee Department of Health Website", "Texas Department of Health Services Website", "United States Centers for Disease Control and Prevention, COVID-19 Response", "Vermont Department of Health, Vermont Center for Geographic Information Open Geodata Portal", "Virginia Department of Health Website", "European Centre for Disease Prevention and Control Website", "World Health Organization COVID-19 Dashboard". The data have been pre-processed into the standard Project Tycho data format v1.1.

Project Tycho datasets contain case counts for reported disease conditions for countries around the world. The Project Tycho data curation team extracts these case counts from various reputable sources, typically from national or international health authorities, such as the US Centers for Disease Control or the World Health Organization. These original data sources include both open- and restricted-access sources. For restricted-access sources, the Project Tycho team has obtained permission for redistribution from data contributors. All datasets contain case count data that are identical to counts published in the original source and no counts have been modified in any way by the Project Tycho team, except for aggregation of individual case count data into daily counts when that was the best data available for a disease and location. The Project Tycho team has pre-processed datasets by adding new variables, such as standard disease and location identifiers, that improve data interpretability. We also formatted the data into a standard data format. All geographic locations at the country and admin1 level have been represented at the same geographic level as in the data source, provided an ISO code or codes could be identified, unless the data source specifies that the location is listed at an inaccurate geographical level. For more information about decisions made by the curation team, recommended data processing steps, and the data sources used, please see the README that is included in the dataset download ZIP file.

This dataset contains large files which can be used to reproduce the results in McDonald, D.J., Bien, J., Green, A., Hu, A.J., DeFries, N., Hyun, S., Oliveira, N.L., Sharpnack, J., Tang, J., Tibshirani, R., Ventura, V., Wasserman, L., and Tibshirani, R.J. “Can Auxiliary Indicators Improve COVID-19 Forecasting and Hotspot Prediction?,” Proceedings of the National Academy of Sciences, 2021. https://doi.org/10.1101/2021.06.22.21259346 Short-term forecasts of traditional streams from public health reporting (such as cases, hospitalizations, and deaths) are a key input to public health decision-making during a pandemic. Since early 2020, our research group has worked with data partners to collect, curate, and make publicly available numerous real-time COVID-19 indicators, providing multiple views of pandemic activity in the U.S. This paper studies the utility of five such indicators---derived from de-identified medical insurance claims, self-reported symptoms from online surveys, and COVID-related Google search activity---from a forecasting perspective. For each indicator, we ask whether its inclusion in an autoregressive (AR) model leads to improved predictive accuracy relative to the same model excluding it. Such an AR model, without external features, is already competitive with many top COVID-19 forecasting models in use today. Our analysis reveals that (a) inclusion of each of these five indicators improves on the overall predictive accuracy of the AR model; (b) predictive gains are in general most pronounced during times in which COVID cases are trending in "flat" or "down" directions; (c) one indicator, based on Google searches, seems to be particularly helpful during "up" trends. Complete descriptions as well as code are available from https://github.com/cmu-delphi/covidcast-pnas/ and are permanently accessible at https://doi.org/10.5281/zenodo.5639567. This material is based on work supported by gifts from Facebook, Google.org, the McCune Foundation, and Optum.

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases among people who received additional or booster doses were reported from 31 jurisdictions; 30 jurisdictions also reported data on deaths among people who received one or more additional or booster dose; 28 jurisdictions reported cases among people who received two or more additional or booster doses; and 26 jurisdictions reported deaths among people who received two or more additional or booster doses. This list will be updated as more jurisdictions participate. Incidence rate estimates: Weekly age-specific incidence rates by vaccination status were calculated as the number of cases or deaths divided by the number of people vaccinated with a primary series, overall or with/without a booster dose (cumulative) or unvaccinated (obtained by subtracting the cumulative number of people vaccinated with a primary series and partially vaccinated people from the 2019 U.S. intercensal population estimates) and multiplied by 100,000. Overall incidence rates were age-standardized using the 2000 U.S. Census standard population. To estimate population counts for ages 6 months through 1 year, half of the single-year population counts for ages 0 through 1 year were used. All rates are plotted by positive specimen collection date to reflect when incident infections occurred. For the primary series analysis, age-standardized rates include ages 12 years and older from April 4, 2021 through December 4, 2021, ages 5 years and older from December 5, 2021 through July 30, 2022 and ages 6 months and older from July 31, 2022 onwards. For the booster dose analysis, age-standardized rates include ages 18 years and older from September 19, 2021 through December 25, 2021, ages 12 years and older from December 26, 2021, and ages 5 years and older from June 5, 2022 onwards. Small numbers could contribute to less precision when calculating death rates among some groups. Continuity correction: A continuity correction has been applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population that would prevent incidence and death rates from growing unrealistically large due to potential overestimates of vaccination coverage. Incidence rate ratios (IRRs): IRRs for the past one month were calculated by dividing the average weekly incidence rates among unvaccinated people by that among people vaccinated with a primary series either overall or with a booster dose. Publications: Scobie HM, Johnson AG, Suthar AB, et al. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1284–1290. Johnson AG, Amin AB, Ali AR, et al. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR Morb Mortal Wkly Rep 2022;71:132–138. Johnson AG, Linde L, Ali AR, et al. COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022. MMWR Morb Mortal Wkly Rep 2023;72:145–152. Johnson AG, Linde L, Payne AB, et al. Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months — 20 U.S. Jurisdictions, September 18, 2022–April 1, 2023. MMWR Morb Mortal Wkly Rep 2023;72:667–669.

Attendance at pa-i-porta and Queen’s gala dinner MGEs and number of contacts (k) to obtain expected cases of COVID-19 compared with observed cases from the formula of Tupper and co-authors [63].

Background: The COVID-19 pandemic disrupted hospital care, as hospitals had to deal with a highly infectious virus, while at the same time continuing to fulfill the ongoing health service needs of their communities. This study examines the direct effects of COVID-19 on the delivery of inpatient care in Croatia.Materials and Methods: The research is a retrospective, comparative analysis of the hospital admission rate across all Diagnosis Related Group (DRG) classes before and during the pandemic. It is based on DRG data from all non-specialized acute hospitals in Croatia, which account for 96% of national inpatient activity. The study also used COVID-19 data from the Croatian Institute of Public Health (CIPH).Results: The results show a 21% decrease in the total number of admissions [incident rate ratio (IRR) 0.8, p < 0.0001] across the hospital network during the pandemic in 2020, with the greatest drop occurring in April, when admissions plunged by 51%. The decrease in activity occurred in non-elective DRG classes such as cancers, stroke, major chest procedures, heart failure, and renal failure. Coinciding with this reduction however, there was a 37% increase (IRR 1.39, p < 0.0001) in case activity across six COVID-19 related DRG classes.Conclusions: The reduction in hospital inpatient activity during 2020, can be attributed to a number of factors such as lock-downs and quarantining, reorganization of hospital operations, the rationing of the medical workforce, and the reluctance of people to seek hospital care. Further research is needed to examine the consequences of disruption to hospital care in Croatia. Our recommendation is to invest multidisciplinary effort in reviewing response procedures to emergencies such as COVID-19 with the aim of minimizing their impact on other, and equally important community health care needs.

Listing of Washoe County COVID-19 case data, by day posted to public dashboard. This table is based on best available information from the Washoe County Health District. Not all fields are populated for all dates.Name FieldName FieldType Comment

OBJECTID OBJECTID ObjectID System generated unique ID

Date Reported reportdt Date Effective date of this row of data

Confirmed confirmed Integer Total number of confirmed cases to date

Recovered recovered Integer Number of recoveries to date

Deaths deaths Integer Number of deaths to date

Active active Integer Current number of active cases

Male Male Small Integer Total confirmed cases to date: Male

Female Female Small Integer Total confirmed cases to date: Female

OtherGender GenderOther Small Integer Total confirmed cases to date: OtherGender

Total Cases 0-9 Age0to9 Small Integer Total confirmed cases to date: Total Cases 0-9

Total Cases 10-19 Age10to19 Small Integer Total confirmed cases to date: Total Cases 10-19

Total Cases 20-29 Age20to29 Small Integer Total confirmed cases to date: Total Cases 20-29

Total Cases 30-39 Age30to39 Small Integer Total confirmed cases to date: Total Cases 30-39

Total Cases 40-49 Age40to49 Small Integer Total confirmed cases to date: Total Cases 40-49

Total Cases 50-59 Age50to59 Small Integer Total confirmed cases to date: Total Cases 50-59

Total Cases 60-69 Age60to69 Small Integer Total confirmed cases to date: Total Cases 60-69

Total Cases 70-79 Age70to79 Small Integer Total confirmed cases to date: Total Cases 70-79

Total Cases 80-89 Age80to89 Small Integer Total confirmed cases to date: Total Cases 80-89

Total Cases 90-99 Age90to99 Small Integer Total confirmed cases to date: Total Cases 90-99

Total Cases 100+ Age100plus Small Integer Total confirmed cases to date: Total Cases 100+

UnknownAge AgeNA Small Integer Total confirmed cases to date: UnknownAge

Native American E_NativeAmerican Integer Total Cases to date: Native American

Asian E_Asian Integer Total Cases to date: Asian

African American E_Black Integer Total Cases to date: African American

Hispanic E_Hispanic Integer Total Cases to date: Hispanic

Hawaiian or Pacific Islander E_HawaiianPacific Integer Total Cases to date: Hawaiian or Pacific Islander

Caucasian E_White Integer Total Cases to date: Caucasian

Multiple E_Multiple Integer Total Cases to date: Multiple

OtherEthnicity E_Other Integer Total Cases to date: OtherEthnicity

EthnicityUnknown E_Unknown Integer Total Cases to date: EthnicityUnknown

New Cases 7 Day Moving Average NewCases7DMA Double Average New Cases over last 7 days

NewCases NewCases Integer New Cases in last day

ActiveCasesAge0to9per100K Age0to9_100K Double Active Cases per 100,000: Age0to9

ActiveCasesAge10to19per100K Age10to19_100K Double Active Cases per 100,000: Age10to19

ActiveCasesAge20to29per100K Age20to29_100K Double Active Cases per 100,000: Age20to29

ActiveCasesAge30to39per100K Age30to39_100K Double Active Cases per 100,000: Age30to39

ActiveCasesAge40to49per100K Age40to49_100K Double Active Cases per 100,000: Age40to49

ActiveCasesAge50to59per100K Age50to59_100K Double Active Cases per 100,000: Age50to59

ActiveCasesAge60to69per100K Age60to69_100K Double Active Cases per 100,000: Age60to69

ActiveCasesAge70to79per100K Age70to79_100K Double Active Cases per 100,000: Age70to79

ActiveCasesAge80to89per100K Age80to89_100K Double Active Cases per 100,000: Age80to89

ActiveCasesAge90to99per100K Age90to99_100K Double Active Cases per 100,000: Age90to99

ActiveCasesAge100plusper100K Age100plus_100K Double Active Cases per 100,000: Age100plus

This thematic research report takes an in-depth look at VR and AR technologies in the FMCG space and it also touches the retail, foodservice and packaging sectors, and it presents related technology, consumer, macroeconomic, and regulatory trends. An industry analysis is also present, highlighting the market size and growth forecasts for VR and AR technologies, key use cases, the impact of VR and AR on FMCG, retail, and foodservice, the Covid-19 impact on the theme, and the mergers and acquisitions for this theme. The report also includes the VR and AR value chains. Lastly, a company’s section is then set, outlining the FMCG companies highly involved in the theme and the nature of their business. Read More

Lejupielādējamo datu datnē ir informācija par 14 dienu paziņoto Covid-19 gadījumu skaitu uz 100 000 iedzīvotāju vecuma grupas, nedēļas un valsts dalījumā. Katrā rindā ir attiecīgie dati par noteiktu nedēļu un valsti. Datne tiek atjaunināta katru nedēļu.

Ja jūs atkārtoti izmantojat vai bagātināsiet šo datu kopu, lūdzu, dalieties ar mums.

شاهد أكثر من 20 مليون مؤشر اقتصادي لـ 196 دولة. احصل على مؤشرات مجانية، وبيانات تاريخية، ورسوم بيانية، وأخبار، وتوقعات لـ 196 دولة.

العدد السنوي للحالات المؤكدة لفيروس كوفيد-19 ومعدل الإصابة لكل 100,000 نسمة في قطر.

Planilla de cálculo principal. Base de datos en función de la información oficial que publicó el Gobierno Nacional durante la pandemia de Covid-19. Está sistematizada día a día hasta el 28 de mayo de 2020. Incluye casos confirmados, activos, recuperados, muertos y tests realizados a nivel nacional. La obtención y utilización de estos datos convergió en el desarrollo de Brooks, una herramienta de software libre destinada a la carga rápida de datos epidemiológicos desde planillas de cálculo que actualmente utilizan epidemiólogos en el contexto de la pandemia por Covid-19. Publicación complementaria https://rdu.unc.edu.ar/handle/11086/15722 Database based on official information released by the National Government during the Covid-19 pandemic. It is systematized day by day until May 28th 2020. It includes confirmed, active, recovered, dead cases and tests carried out at national level. The collection and use of this data converged in the development of Brooks, an open-source tool for rapid loading of epidemiological data from spreadsheets currently used by epidemiologists in the context of the Covid-19 pandemic. Complementary publication https://rdu.unc.edu.ar/handle/11086/15722